[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-merck-slips-as-keytruda-vaccine-combo-cuts-melanoma-recurrence-risk-by-42-KO":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":344},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},143736,"머크 주가 하락, 키트루다 백신 병용 요법이 흑색종 재발 위험 42% 감소","2026-10-23T13:00:00","2026-10-22T19:42:26","\u003Cp>머크의 흑색종 백신(모더나와 공동 개발)이 재발 또는 사망 위험을 42% 감소시켰음에도, 3분기 실적 발표를 앞두고 주가는 하락했습니다.\u003C\u002Fp>","\u003Ch3 id=\"h-key-takeaways\" class=\"wp-block-heading\">핵심 요약\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>머크와 모더나는 인티스메란 플러스 키트루다가 흑색종 재발 또는 사망 위험을 42% 감소시켰으며, 2년차에 82.2%의 환자가 암이 없는 상태를 유지했다고 발표했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>머크 주가는 0.8% 하락한 $149에 거래되었는데, 이는 투자자들이 이미 8월의 주요 결과 발표 이후 승리를 주가에 반영했기 때문입니다.\u003C\u002Fli>\n\n\n\n\u003Cli>키트루다는 여전히 매출의 약 절반을 차지하며, 핵심 미국 특허 보호는 2028년에 만료됩니다. 애널리스트들은 연간 EPS 성장률이 1.6%에 그칠 것으로 예상합니다.\u003C\u002Fli>\n\n\n\n\u003Cli>10월 24일 ESMO에서의 전체 데이터와 10월 29일 3분기 실적 발표는 이 백신 이야기가 얼마나 더 가치를 더할 수 있는지 보여줄 것입니다.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>머크 앤드 컴퍼니 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=288502&amp;tid=2629738\">MRK\u003C\u002Fa>)\u003C\u002Fstrong>는 마침내 맞춤형 암 백신이 키트루다의 효과를 높일 수 있다는 3상 임상 결과를 확보했습니다. 그럼에도 불구하고 주가는 0.8% 하락한 $149에 거래되었습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">달력을 탓하세요. 머크와 \u003Cstrong>모더나 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=128680956&amp;tid=591065499\">MRNA\u003C\u002Fa>)\u003C\u002Fstrong>는 이미 8월에 인티스메란 아우토진이 흑색종에서 주요 목표를 달성했다고 발표했고, 머크 주가는 그날 오전 최대 11%까지 뛰었습니다. 따라서 목요일 발표된 수치는 투자자들이 이미 주가에 반영해 놓은 승리를 확인한 것에 불과합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">모더나 주가도 하락했는데, 소셜 미디어 게시물에서 데이터가 조기에 유출된 가능성을 지적했기 때문입니다. (mRNA 암 백신의 첫 긍정적인 후기 단계 결과를 공개하는 가장 깔끔한 방법은 아니었습니다.)\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">머크 주주들에게 중요한 질문은 단일 임상 시험 이상입니다. \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fkeytruda-just-did-8-billion-in-a-quarter-heres-why-merck-stock-still-looks-cheap\">키트루다의 핵심 미국 특허가 2028년에 만료될 때\u003C\u002Fa>, 키트루다와 함께 판매되는 약물이 타격을 완충하는 데 도움이 될 수 있을까요?\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">12포인트 차이\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">주요 결과는 8월의 약속과 일치했으며, 이제 세부 사항이 공개되었습니다:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>IIB기에서 IV기 흑색종으로 절제술을 받은 1,137명의 환자\u003C\u002Fli>\n\n\n\n\u003Cli>키트루다 단독 요법 대비 재발 또는 사망 위험 42% 감소\u003C\u002Fli>\n\n\n\n\u003Cli>2년차에 82.2%가 생존하며 암이 없는 상태 유지 (키트루다 단독 요법 대비 70%)\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">이는 중기 연구 결과와 일치하는데, 해당 연구에서는 조합 요법이 5년 후 재발 또는 사망 위험을 49% 감소시켰습니다. 전체 결과는 10월 24일 ESMO에서 공개될 예정이며, 투자자들은 원격 전이와 조기 생존 신호에 가장 주목할 것입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">모더나의 스티븐 호지(Stephen Hoge) 사장은 8월 인터뷰에서 규제 당국의 승인을 받는다면 내년에 수천 명의 환자가 이 백신의 혜택을 볼 수 있을 것이라고 말했습니다. 이 타임라인은 중요합니다. 2028년 이전 매출이 쌓이는 매년이 키트루다의 영향력 아래에서 이루어지기 때문입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">그렇다면 주가는 실제로 어디서 반응했을까요?\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"images\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA\" alt=\"Merck &amp; Co. (MRK): share price, $, last 1 year\" class=\"wp-post-143736 wp-image-143761\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792697891\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 3026w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792697891\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price\u002FTIKR.com_Merck-Co.-Inc.-MRK-Stock-Price.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3026px) 100vw, 3026px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Merck &amp; Co. (MRK): 주가, $, 지난 1년 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">지난 1년간 머크의 76.1% 총수익률은 그 여름 결과 발표에 많은 부분을 빚지고 있으며, 이번 주의 무관심을 설명해 줍니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">키트루다는 파트너가 필요하다\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">키트루다는 여전히 머크를 떠받치고 있습니다. 2분기 키트루다 및 키트루다 큐렉스 매출은 5% 증가한 $83.7억 달러로, 총 매출 $166.1억 달러의 약 절반을 차지했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">경영진은 이후 2026년 매출 전망을 $663억~$673억 달러로, 조정 EPS 전망을 $9.30~$9.45로 상향 조정했습니다. 가다실 매출은 3% 증가에 그쳐 $11.7억 달러를 기록했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">인티스메란은 키트루다 문제에 잘 맞습니다. 의사들이 키트루다와 함께 투여하기 때문입니다. 조합 요법을 받는 모든 환자는 동시에 키트루다 환자이며, 근육 침습성 방광암 치료제로 키트루다 플러스 패드세브가 EU에서 새로 승인받은 것도 같은 방식으로 작동합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>바클레이즈 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=600807104&amp;tid=708490470\">BCS\u003C\u002Fa>)\u003C\u002Fstrong> 애널리스트들은 이 백신이 2035년까지 흑색종에서 연간 약 $30억 달러의 매출을 달성할 것으로 예상합니다. 그러나 머크는 비용과 이익을 모더나와 균등하게 분배하므로, 그 몫은 더 작습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">한편, 합의된 예상치는 겸손한 상위라인 성장만을 기대하고 있습니다...\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792697918\u002Fimages\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue_143763ef00c\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue_143763ef00c.webp?_i=AA\" alt=\"Merck &amp; Co. (MRK): revenue, actual and consensus estimates, $ billions, fiscal 2021–2030\" class=\"wp-post-143736 wp-image-143763\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792697918\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Merck &amp; Co. (MRK): 매출, 실적 및 합의 추정치, $10억 달러, 2021–2030 회계연도 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">$15억 달러 규모의 백신 몫은 연간 $330억 달러 이상을 기록하는 키트루다 프랜차이즈에 거의 영향을 미치지 못할 것입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR은 머크에 대해 27명의 애널리스트를 추적합니다. 몇 명이 '매수' 의견일까요?\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">머크에 대한 매수, 보유, 매도 등급의 전체 분포와 월스트리트의 매출 및 수익 추정치를 한곳에서 확인하세요. 50만 명 이상의 투자자가 TIKR을 사용하여 이와 같은 주식을 조사합니다. \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">머크의 애널리스트 등급 보기\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">2028년 이후의 계산\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">합의된 예상치는 머크의 EPS가 향후 2년간 연간 1.6%만 성장할 것으로 보며, EBITDA는 실질적으로 0.1%로 정체 상태입니다. \u003Cstrong>아비비 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=141885706&amp;tid=225079155\">ABBV\u003C\u002Fa>)\u003C\u002Fstrong>는 이미 자사의 휴미라 클리프를 극복했으며 연간 27.3%의 EPS 성장률을 보이고, \u003Cstrong>존슨앤드존슨 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=139677&amp;tid=2623227\">JNJ\u003C\u002Fa>)\u003C\u002Fstrong>은 3.8%에 머물고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">공시된 수익은 더욱 복잡해 보입니다. 머크의 최근 배당성향은 261.5%인데, 이는 인수한 파이프라인 비용이 1분기 조정 손실을 주당 $1.28로 끌어올렸기 때문입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">또한 새로운 법적 장애물도 있습니다. \u003Cstrong>할로자임 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&amp;ref=meufz8&amp;cid=7931206&amp;tid=9296998\">HALO\u003C\u002Fa>)\u003C\u002Fstrong>은 이번 달에 유럽 여러 시장에서 키트루다 피하주사제 버전의 제조와 판매를 중단하는 금지 명령을 받았으며, 이 포맷은 바이오시밀러가 출시된 후 환자를 유지하려는 머크의 계획의 핵심입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">시장은 이러한 성장 격차를 매우 다르게 평가하고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"images\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA\" alt=\"\" class=\"wp-post-143736 wp-image-143765\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792697917\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 3026w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792697917\u002Fimages\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1\u002FTIKR.com_Merck-Co.-Inc.-MRK-NTM-Price-_-Normalized-Earnings-P_E-1.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3026px) 100vw, 3026px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Merck &amp; Co. (MRK): 선행 (NTM) P\u002FE 대비 아비비와 존슨앤드존슨, 지난 5년 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">J&amp;J는 선행 수익 대비 23.2배, 아비비는 18.9배에 거래되며, 둘 다 오늘날의 머크보다 더 명확한 성장 스토리를 가지고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">제 생각: 인티스메란은 진정한 자산이자 현명한 조합입니다. 키트루다를 치료 요법에 유지시키기 때문입니다. 그러나 2035년까지 공유하는 $30억 달러 규모의 기회는 $330억 달러 규모의 약물을 대체할 수 없습니다. 따라서 주가의 다음 국면은 윈레베어, 키트루다 큐렉스 전환, 그리고 머크가 계속 체결하는 거래에 달려 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">10월 29일 3분기 실적이 다음 검증 지점입니다. 키트루다 성장, 가다실 회복 가능성, 그리고 2027년 초에 대한 논평을 살펴보세요.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-so-what-is-merck-stock-actually-worth\" class=\"wp-block-heading\">\u003Cstrong>그렇다면 머크 주식의 실제 가치는 얼마일까요?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR을 사용하면 1분 이내에 모든 주식의 미래 가격을 예측할 수 있습니다. TIKR의 가치 평가 모델에 몇 가지 가정을 입력하기만 하면 머크의 잠재적 가치를 확인할 수 있습니다. 월스트리트 합의 추정치에서 시작하거나, 비즈니스에 대한 자신의 견해를 반영하여 입력값을 조정하세요. 무료로 사용할 수 있습니다. \u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>MRK의 가치를 무료로 평가하세요\u003C\u002Fstrong>\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>면책 조항:\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" id=\"h-\">\u003Cem>TIKR의 기사는 TIKR이나 저희 콘텐츠 팀의 투자 또는 재정 조언으로 의도된 것이 아니며, 어떠한 주식을 사거나 팔라는 권고도 아닙니다. 저희는 TIKR 터미널의 투자 데이터와 애널리스트들의 추정치를 바탕으로 콘텐츠를 작성합니다. 저희 분석에는 최근의 기업 뉴스나 중요한 업데이트가 포함되지 않을 수 있습니다. TIKR은 언급된 모든 주식에 대해 포지션을 보유하고 있지 않습니다. 읽어주셔서 감사합니다, 행운 있는 투자 되세요!\u003C\u002Fem>\u003C\u002Fp>",980,"ko","\u002Fblog\u002Fmerck-slips-as-keytruda-vaccine-combo-cuts-melanoma-recurrence-risk-by-42","merck-slips-as-keytruda-vaccine-combo-cuts-melanoma-recurrence-risk-by-42","images\u002FMRK-stock_1437469bc50\u002FMRK-stock_1437469bc50","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792695966\u002Fimages\u002FMRK-stock_1437469bc50\u002FMRK-stock_1437469bc50.png?_i=AA",{"altText":237,"imageCredit":238},"Merck Slips as Keytruda Vaccine Combo Cuts Melanoma Recurrence Risk by 42%","Blvckshot and Rulles from Getty Images via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Rexielyn Diaz","rexietikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"David Hanson","davidtikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"일반 투자","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Merck’s melanoma vaccine with Moderna cut recurrence or death risk by 42%, yet shares slipped ahead of Q3.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","예상 독서 시간","5 minutes",1200,630,[266,283,297,314,329],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":280,"relatedPosts":282},"SpaceX, 8만 개의 셀룰러 사이트 접근권 협상 중 무선 네트워크 구축 위해","2026-10-23 12:55:00","SpaceX가 80,000개의 미국 셀 사이트 접근권을 확보하기 위한 협상을 진행 중이라고 보도되었습니다. 이는 SpaceX 주식과 주요 무선 통신사들에 어떤 의미를 가질 수 있을지 살펴봅니다.",521,"\u002Fblog\u002Fspacex-stock-80000-cell-sites-wireless-network","spacex-stock-80000-cell-sites-wireless-network","images\u002FSPCX-stock-@Kmeel_com-from-pixabay-via-Canva-@3DSculptor-from-Getty-Images-via-Canva-12\u002FSPCX-stock-@Kmeel_com-from-pixabay-via-Canva-@3DSculptor-from-Getty-Images-via-Canva-12","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792726910\u002Fimages\u002FSPCX-stock-@Kmeel_com-from-pixabay-via-Canva-@3DSculptor-from-Getty-Images-via-Canva-12\u002FSPCX-stock-@Kmeel_com-from-pixabay-via-Canva-@3DSculptor-from-Getty-Images-via-Canva-12.png?_i=AA",{"altText":267},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":279},"Aditya Raghunath","adityatikr",[],[281],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":284,"date":268,"excerpt":285,"wordCount":286,"uri":287,"slug":288,"cloudinaryAssetId":289,"featuredImageOriginalUrl":290,"featuredImageMetadata":291,"author":292,"categories":294,"relatedPosts":296},"제너럴 모터스, 미국 제조업체와의 희토류 공급 계약 취소","GM이 미국 제조사와의 희토류 자석 거래를 취소했으며 양측은 중재 절차 중입니다. GM 주식에 대한 시사점은 다음과 같습니다.",620,"\u002Fblog\u002Fgeneral-motors-stock-cancels-rare-earth-magnet-supply-deal","general-motors-stock-cancels-rare-earth-magnet-supply-deal","images\u002FGM-stock-@Benjamin44-from-Getty-Images-Pro-via-Canva-@contrastaddict-from-Getty-Images-Signature-via-Canva-6_144090c966b\u002FGM-stock-@Benjamin44-from-Getty-Images-Pro-via-Canva-@contrastaddict-from-Getty-Images-Signature-via-Canva-6_144090c966b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792732281\u002Fimages\u002FGM-stock-@Benjamin44-from-Getty-Images-Pro-via-Canva-@contrastaddict-from-Getty-Images-Signature-via-Canva-6_144090c966b\u002FGM-stock-@Benjamin44-from-Getty-Images-Pro-via-Canva-@contrastaddict-from-Getty-Images-Signature-via-Canva-6_144090c966b.png?_i=AA",{"altText":284},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":293},[],[295],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":298,"date":299,"excerpt":300,"wordCount":301,"uri":302,"slug":303,"cloudinaryAssetId":304,"featuredImageOriginalUrl":305,"featuredImageMetadata":306,"author":307,"categories":311,"relatedPosts":313},"Bank of America가 한 달 만에 12% 하락했습니다. 매도할 때일까, 아니면 대량 매수할 때일까?","2026-10-23 12:46:53","Bank of America 주가는 12억 1,000만 달러 규제 벌금과 엇갈린 실적 발표 이후 한 달 만에 약 13% 하락했습니다. BAC의 밸류에이션, 증가하는 순이자 수익, 그리고 월스트리트의 전망이 매수 기회를 시사할 수 있는 이유는 다음과 같습니다.",623,"\u002Fblog\u002Fbank-of-america-just-dropped-12-in-a-month-is-it-time-to-sell-or-load-up","bank-of-america-just-dropped-12-in-a-month-is-it-time-to-sell-or-load-up","images\u002FBAC-stock-chidemicheal-from-pixabay-and-Elena-Photo-via-Canva_14398286d3d\u002FBAC-stock-chidemicheal-from-pixabay-and-Elena-Photo-via-Canva_14398286d3d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792701002\u002Fimages\u002FBAC-stock-chidemicheal-from-pixabay-and-Elena-Photo-via-Canva_14398286d3d\u002FBAC-stock-chidemicheal-from-pixabay-and-Elena-Photo-via-Canva_14398286d3d.png?_i=AA",{"altText":298},{"name":308,"slug":309,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":310},"Nikko Henson","nikkotikr",[],[312],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":315,"date":316,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":326,"relatedPosts":328},"마이크로소프트 AI 진단 도구, 의학 연구에서 의사들보다 더 우수한 성능 보여","2026-10-23 12:38:00","마이크로소프트의 AI 진단 도구가 새로운 사이언스 연구에서 의사들을 앞섰습니다. 이 결과가 마이크로소프트 주식에 어떤 의미를 가질 수 있는지 살펴봅니다.",635,"\u002Fblog\u002Fmicrosoft-stock-ai-diagnostic-tool-outperforms-physicians","microsoft-stock-ai-diagnostic-tool-outperforms-physicians","images\u002FMSFT-stock-@Natee-Meepians-Images-via-Canva-@200degrees-via-Canva-4\u002FMSFT-stock-@Natee-Meepians-Images-via-Canva-@200degrees-via-Canva-4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792729293\u002Fimages\u002FMSFT-stock-@Natee-Meepians-Images-via-Canva-@200degrees-via-Canva-4\u002FMSFT-stock-@Natee-Meepians-Images-via-Canva-@200degrees-via-Canva-4.png?_i=AA",{"altText":315},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":325},[],[327],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":330,"date":331,"excerpt":332,"wordCount":333,"uri":334,"slug":335,"cloudinaryAssetId":336,"featuredImageOriginalUrl":337,"featuredImageMetadata":338,"author":339,"categories":341,"relatedPosts":343},"Moderna와 Merck 암 백신, 흑색종 사망 위험 42% 감소","2026-10-23 12:02:00","Moderna와 Merck의 암 백신이 흑색종 사망 위험을 42% 감소시켰습니다. 이 임상 시험 결과가 Merck 주식과 Keytruda에 어떤 의미를 가지는지 살펴봅니다.",595,"\u002Fblog\u002Fmerck-stock-moderna-melanoma-vaccine-42-percent","merck-stock-moderna-melanoma-vaccine-42-percent","images\u002FMRK-stock-@Peopleimages.com-YuriArcurs-via-Canva-@Yau-Ming-Low-from-Getty-Images-via-Canva_144085c5b16\u002FMRK-stock-@Peopleimages.com-YuriArcurs-via-Canva-@Yau-Ming-Low-from-Getty-Images-via-Canva_144085c5b16","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792730758\u002Fimages\u002FMRK-stock-@Peopleimages.com-YuriArcurs-via-Canva-@Yau-Ming-Low-from-Getty-Images-via-Canva_144085c5b16\u002FMRK-stock-@Peopleimages.com-YuriArcurs-via-Canva-@Yau-Ming-Low-from-Getty-Images-via-Canva_144085c5b16.png?_i=AA",{"altText":330},{"name":277,"slug":278,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":340},[],[342],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[345,365,381,396,411],{"id":255,"title":346,"date":347,"excerpt":348,"wordCount":349,"uri":350,"slug":351,"cloudinaryAssetId":352,"featuredImageOriginalUrl":353,"featuredImageMetadata":354,"author":355,"categories":359,"relatedPosts":364},"IREN 주식, 스페인 캠퍼스 랠리 이후 하루 만에 8% 하락. 월스트리트 목표가가 시사하는 바는 다음과 같습니다","2026-10-23 07:20:00","IREN은 네오클라우드 주식들이 부채 우려로 매도되면서 스페인 캠퍼스 상승분을 단 하루 만에 되돌렸습니다. 300MW 바다호스 라이선스는 용량을 추가하지만, IREN은 아직 데이터센터를 담보로 한 대출을 마무리하지 못했습니다. 애널리스트들의 12개월 목표가가 시사하는 바는 다음과 같습니다.",908,"\u002Fblog\u002Firen-stock-fell-8-in-a-day-after-its-spain-campus-rally-heres-what-wall-streets-targets-imply","iren-stock-fell-8-in-a-day-after-its-spain-campus-rally-heres-what-wall-streets-targets-imply","images\u002F18_14404989fa4\u002F18_14404989fa4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717505\u002Fimages\u002F18_14404989fa4\u002F18_14404989fa4.png?_i=AA",{"altText":346},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":358},"Wiltone Asuncion","wiltonetikr",[],[360],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},"주식 리뷰","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":255,"title":366,"date":367,"excerpt":368,"wordCount":369,"uri":370,"slug":371,"cloudinaryAssetId":372,"featuredImageOriginalUrl":373,"featuredImageMetadata":374,"author":376,"categories":378,"relatedPosts":380},"Hims & Hers 주가, 최대 규모 남성 건강 제품 출시 이후 거의 움직이지 않아. 11월 9일이 보여준 것은 다음과 같다","2026-10-23 07:15:00","Hims & Hers는 10월 21일에 주사용 및 경구용 테스토스테론을 출시했으며, 그 이후 주가는 거의 움직이지 않았습니다. 경영진은 8월에 이 출시를 약속했으며, 테스토스테론이 1억 달러의 연간화된 페이스(run-rate)에 도달할 것으로 예상합니다. 12월 31일 DEA 마감일과 11월 9일 실적 발표가 다음 시험대가 될 것입니다.",977,"\u002Fblog\u002Fhims-hers-stock-has-barely-moved-since-its-biggest-mens-health-launch-heres-what-november-9-has-to-show","hims-hers-stock-has-barely-moved-since-its-biggest-mens-health-launch-heres-what-november-9-has-to-show","images\u002F17_144048ee756\u002F17_144048ee756","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717512\u002Fimages\u002F17_144048ee756\u002F17_144048ee756.png?_i=AA",{"altText":375},"Hims &amp; Hers 주가, 최대 규모 남성 건강 제품 출시 이후 거의 움직이지 않아. 11월 9일이 보여준 것은 다음과 같다",{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":377},[],[379],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":382,"date":383,"excerpt":384,"wordCount":385,"uri":386,"slug":387,"cloudinaryAssetId":388,"featuredImageOriginalUrl":389,"featuredImageMetadata":390,"author":391,"categories":393,"relatedPosts":395},"브로드컴 주가 4% 하락, 반도체주 하락세 속 10년 만의 VMware 인수 후 며칠 지나... 월가의 목표가가 말하는 것","2026-10-23 07:10:00","브로드컴은 10월 22일 반도체주가 하락에 따라 4.31% 하락했으며, 이는 일본에서 첫 10년간 VM웨어 계약을 체결한 지 며칠 지나지 않아 발생한 일입니다. 이익 예측은 계속 상승하고 있지만, 주가는 2월 수준보다 낮게 거래되고 있습니다.",903,"\u002Fblog\u002Fbroadcom-stock-fell-4-as-chip-stocks-slid-days-after-a-10-year-vmware-deal-heres-what-wall-streets-targets-say","broadcom-stock-fell-4-as-chip-stocks-slid-days-after-a-10-year-vmware-deal-heres-what-wall-streets-targets-say","images\u002F16-1_14404727574\u002F16-1_14404727574","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717515\u002Fimages\u002F16-1_14404727574\u002F16-1_14404727574.png?_i=AA",{"altText":382},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":392},[],[394],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":397,"date":398,"excerpt":399,"wordCount":400,"uri":401,"slug":402,"cloudinaryAssetId":403,"featuredImageOriginalUrl":404,"featuredImageMetadata":405,"author":406,"categories":408,"relatedPosts":410},"Nebius 주식이 35억 달러 Citi 시설 발표 당일 7% 하락했습니다. AI 칩 부족이 얼마나 지속될지에 대한 CEO의 발언은 다음과 같습니다.","2026-10-23 07:00:00","Nebius는 10월 22일 35억 달러 규모의 364일 만기 Citi 시설을 발표한 날 7.23% 하락했으며, CoreWeave와 IREN은 2026년 최저치로 떨어졌습니다. 9월에 해당 회사의 CEO는 AI 컴퓨팅 공급이 수요를 따라잡는 대략적인 시기를 언급했습니다. 그 시기는 새로운 거래의 투자 회수 기간과 가깝습니다.",784,"\u002Fblog\u002Fnebius-stock-fell-7-the-day-it-announced-a-3-5-billion-citi-facility-heres-what-its-ceo-said-about-how-long-the-ai-chip-shortage-lasts","nebius-stock-fell-7-the-day-it-announced-a-3-5-billion-citi-facility-heres-what-its-ceo-said-about-how-long-the-ai-chip-shortage-lasts","images\u002F14-1_144045ee128\u002F14-1_144045ee128","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717438\u002Fimages\u002F14-1_144045ee128\u002F14-1_144045ee128.png?_i=AA",{"altText":397},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":407},[],[409],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":412,"date":413,"excerpt":414,"wordCount":415,"uri":416,"slug":417,"cloudinaryAssetId":418,"featuredImageOriginalUrl":419,"featuredImageMetadata":420,"author":421,"categories":423,"relatedPosts":425},"머크, 유럽에서 키트루다의 방광암 적응증 확대 승인. ESMO 데이터에서 보여야 할 것은 다음과 같습니다","2026-10-22 21:00:00","유럽이 키트루다와 패드세브 병용 요법을 시스플라틴 적격성과 무관하게 방광암 환자로 확대했습니다. 3일 후, ESMO에서 머크의 암 백신이 연구 책임자가 설정한 기준을 통과하는지 여부가 공개됩니다.",836,"\u002Fblog\u002Fmerck-won-a-wider-eu-bladder-cancer-label-for-keytruda-heres-what-its-esmo-data-needs-to-show","merck-won-a-wider-eu-bladder-cancer-label-for-keytruda-heres-what-its-esmo-data-needs-to-show","images\u002F13-7_1439568ebea\u002F13-7_1439568ebea","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792700551\u002Fimages\u002F13-7_1439568ebea\u002F13-7_1439568ebea.png?_i=AA",{"altText":412},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":422},[],[424],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[]]